Recursion Pharmaceuticals Stock Price History

RXRX Stock  USD 5.89  0.11  1.83%   
If you're considering investing in Recursion Stock, it is important to understand the factors that can impact its price. As of today, the current price of Recursion Pharmaceuticals stands at 5.89, as last reported on the 27th of November, with the highest price reaching 6.06 and the lowest price hitting 5.83 during the day. Recursion Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0631, which implies the firm had a -0.0631% return per unit of risk over the last 3 months. Recursion Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Recursion Pharmaceuticals' Risk Adjusted Performance of (0.06), coefficient of variation of (1,193), and Variance of 17.67 to confirm the risk estimate we provide.
  
At this time, Recursion Pharmaceuticals' Other Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 56.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 255.6 M in 2024. . At this time, Recursion Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 4.64 in 2024, whereas Price To Sales Ratio is likely to drop 43.68 in 2024. Recursion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0631

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRXRX

Estimated Market Risk

 4.23
  actual daily
37
63% of assets are more volatile

Expected Return

 -0.27
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.06
  actual daily
0
Most of other assets perform better
Based on monthly moving average Recursion Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Recursion Pharmaceuticals by adding Recursion Pharmaceuticals to a well-diversified portfolio.
Price Book
4.3654
Enterprise Value Ebitda
(5.31)
Price Sales
35.1299
Shares Float
252.4 M
Wall Street Target Price
9.8571

Recursion Pharmaceuticals Stock Price History Chart

There are several ways to analyze Recursion Stock price data. The simplest method is using a basic Recursion candlestick price chart, which shows Recursion Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 11, 20247.84
Lowest PriceNovember 22, 20245.7

Recursion Pharmaceuticals November 27, 2024 Stock Price Synopsis

Various analyses of Recursion Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Recursion Stock. It can be used to describe the percentage change in the price of Recursion Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Recursion Stock.
Recursion Pharmaceuticals Price Action Indicator(0.11)
Recursion Pharmaceuticals Price Daily Balance Of Power(0.48)
Recursion Pharmaceuticals Price Rate Of Daily Change 0.98 

Recursion Pharmaceuticals November 27, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Recursion Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Recursion Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Recursion Stock and then apply it to test your longer-term investment strategies against Recursion.

Recursion Stock Price History Data

The price series of Recursion Pharmaceuticals for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 2.19 with a coefficient of variation of 7.49. The price distribution for the period has arithmetic mean of 6.61. The median price for the last 90 days is 6.62.
OpenHighLowCloseVolume
11/27/2024
 5.97  6.06  5.83  5.89 
11/26/2024 5.97  6.06  5.83  5.89  8,502,677 
11/25/2024 5.94  6.48  5.83  6.00  20,384,254 
11/22/2024 5.78  5.99  5.60  5.70  13,671,529 
11/21/2024 6.02  6.03  5.62  5.75  12,335,460 
11/20/2024 6.30  6.37  5.70  6.04  16,994,928 
11/19/2024 6.01  6.33  5.84  6.27  9,335,206 
11/18/2024 6.25  6.26  5.90  6.10  10,410,499 
11/15/2024 6.89  6.92  6.15  6.18  10,534,833 
11/14/2024 7.39  7.58  6.88  6.91  6,568,267 
11/13/2024 7.80  8.04  7.31  7.32  6,585,044 
11/12/2024 7.52  8.05  7.43  7.58  6,801,234 
11/11/2024 7.50  8.49  7.23  7.84  15,568,777 
11/08/2024 6.86  7.21  6.81  7.10  6,659,976 
11/07/2024 6.92  7.09  6.68  6.93  5,792,406 
11/06/2024 6.95  7.05  6.77  6.97  7,329,629 
11/05/2024 6.59  6.83  6.47  6.82  4,353,767 
11/04/2024 6.40  6.69  6.22  6.64  3,884,573 
11/01/2024 6.36  6.58  6.34  6.40  3,629,375 
10/31/2024 6.65  6.69  6.32  6.32  4,376,478 
10/30/2024 6.62  6.90  6.60  6.68  4,469,167 
10/29/2024 6.85  6.85  6.65  6.74  2,494,247 
10/28/2024 6.58  6.95  6.56  6.87  4,544,060 
10/25/2024 6.42  6.61  6.28  6.48  3,517,517 
10/24/2024 6.45  6.45  6.20  6.36  2,934,269 
10/23/2024 6.55  6.63  6.24  6.33  3,976,583 
10/22/2024 6.70  6.79  6.56  6.61  2,842,272 
10/21/2024 6.94  6.94  6.59  6.76  3,951,006 
10/18/2024 6.57  6.95  6.57  6.94  3,629,000 
10/17/2024 7.10  7.10  6.54  6.55  4,852,710 
10/16/2024 6.75  7.07  6.71  7.01  4,524,578 
10/15/2024 6.72  6.77  6.49  6.67  2,575,843 
10/14/2024 6.64  6.81  6.52  6.72  3,607,638 
10/11/2024 6.11  6.67  6.06  6.62  5,395,922 
10/10/2024 6.09  6.21  5.95  6.18  4,979,315 
10/09/2024 6.49  6.63  6.09  6.15  5,721,030 
10/08/2024 6.18  6.49  6.14  6.44  3,768,282 
10/07/2024 6.12  6.19  6.03  6.18  3,484,481 
10/04/2024 6.15  6.34  6.07  6.11  3,848,056 
10/03/2024 6.08  6.18  6.04  6.06  4,307,462 
10/02/2024 6.19  6.41  6.07  6.11  4,762,299 
10/01/2024 6.51  6.58  6.07  6.17  7,253,090 
09/30/2024 6.89  7.10  6.59  6.59  5,318,335 
09/27/2024 7.23  7.30  6.97  6.98  3,615,037 
09/26/2024 7.00  7.18  6.80  7.17  6,570,547 
09/25/2024 6.86  7.12  6.81  6.89  3,261,502 
09/24/2024 6.72  6.95  6.68  6.84  2,868,375 
09/23/2024 6.74  6.80  6.63  6.67  3,538,847 
09/20/2024 6.86  6.90  6.71  6.80  17,150,930 
09/19/2024 7.16  7.24  6.90  6.94  4,630,941 
09/18/2024 6.81  7.41  6.81  6.91  6,054,797 
09/17/2024 6.73  7.04  6.73  6.76  4,151,668 
09/16/2024 6.56  6.67  6.40  6.65  3,011,100 
09/13/2024 6.60  6.76  6.44  6.57  3,755,126 
09/12/2024 6.44  6.64  6.25  6.50  3,443,686 
09/11/2024 6.18  6.51  6.17  6.45  2,941,721 
09/10/2024 6.16  6.32  6.06  6.32  3,086,240 
09/09/2024 5.95  6.13  5.91  6.12  3,985,663 
09/06/2024 6.16  6.30  5.90  5.92  4,575,092 
09/05/2024 6.14  6.33  6.04  6.17  3,479,645 
09/04/2024 6.05  6.23  5.89  6.10  5,709,827 

About Recursion Pharmaceuticals Stock history

Recursion Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Recursion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Recursion Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Recursion Pharmaceuticals stock prices may prove useful in developing a viable investing in Recursion Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding207.9 M194.8 M
Net Loss-215.5 M-226.3 M

Recursion Pharmaceuticals Quarterly Net Working Capital

436.29 Million

Recursion Pharmaceuticals Stock Technical Analysis

Recursion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Recursion Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Recursion Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Recursion Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Recursion Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Recursion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Recursion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Recursion Stock Analysis

When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.